Medicare Spending on Hepatitis-C Drugs More than Doubled
July 14, 2016
Risk of cancer in rheumatoid arthritis patients taking biologic therapy (tumor necrosis factor antagonists)
July 14, 2016
Show all

MS Patient’s ‘Pick of the Week’ News 

Some top picks among the many news items reported the past week by writers for Multiple Sclerosis News Today.

It will come as no surprise to those of us with MS that disabling tremors, which apparently can affect as many as half of all us, are inadequately treated. This is because of limited therapeutic options and because such tremors are not sufficiently being studied, researchers at the University of Alabama at Birmingham reported.

Their report, “Symptomatic Management of Multiple Sclerosis-Associated Tremor Among Participants in the NARCOMS Registry,” was published in theInternational Journal of MS Care.

We patients with MS are faced with a number of disabling symptoms that affect our capacity to do things, and our quality of life. Drugs approved in recent years improve some symptoms, such as gait or emotional responses, but other symptoms are often managed with drugs in an off-label manner, meaning the drug is not approved for such use. The researchers said their study revealed an urgent need for symptomatic treatments of tremors.

Read Full Article: MS Patient’s ‘Pick of the Week’ News in Multiple Sclerosis News Today

Read Full Article: MS Patient’s ‘Pick of the Week’ News in Multiple Sclerosis News Today

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.